Bayer Can't Block Generic Xarelto, And Has Patent Nixed
Bayer can't stop a French generic-drug maker from putting a cheaper version of its blockbuster blood thinner Xarelto on pharmacy shelves, after a French court nixed its dosage patent....To view the full article, register now.
Already a subscriber? Click here to view full article